European Leukemia Trial Registry
Trial: MDS Decitabine

More Details
Scientific Title A phase II study of Decitabine in patients with chronic Myelomonocytic Leukemia
Short Title MDS Decitabine
Trialgroup Groupe Francophone des Myélodysplasies
Disease Chronic myeloic leukemia(CML) All subtypes
Myelodysplastic Syndrome(MDS) All subtypes
Age -
Status Active
Start of Recruitment 01.03.2008
Leader Solary, MD, Eric
Shortprotocol Shortprotocol
created 04.03.2010 Irene Gleske
changed 05.03.2010 Irene Gleske
© 2006 ELIC European Leukemia Information Center (Dr. N. Gökbuget, Dr. S. Schäfer) | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org